PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Real-time biopsies uncover hidden response to glioblastoma therapy

Early clinical trial results show that serial brain biopsies reveal immune activity in brain cancer not captured by standard scans

2025-10-08
(Press-News.org) (CAMBRIDGE, MASS.) October 08, 2025 – A new study led by Break Through Cancer’s Accelerating Glioblastoma (GBM) Therapies Through Serial Biopsies TeamLab has revealed that an engineered virus therapy, CAN-3110, triggered powerful immune responses deep inside glioblastoma tumors that were invisible to standard imaging like MRI, according to early analyses of two patients with recurrent GBM.

Published today in Science Translational Medicine, the research highlights the TeamLab’s innovative approach of combining serial brain biopsies (tiny pieces of brain tissue removed while a patient is being treated) with advanced multi-omics analyses, can uncover dynamic changes in recurrent GBM. This is the first time scientists have mapped, in high-resolution, how oncolytic virus therapy reshaped the brain microenriornment in real-time.

The study involved two patients with recurrent GBM who underwent serial biopsies over four months of CAN-3110 treatment. Not only was the procedure well tolerated in these patients, but it also enabled an unprecedented level of insight into how tumors evolve during therapy. Standard practice is to not sample a patient’s brain tumor as they undergo treatment rather, to sample only before treatment and then measure responses using MRI. But these findings suggest that this thinking and practice may need to change to revolutionize how patients can monitor their disease. Completion of the trial is required to help answer this question.

“This gives us a real-time window into what is happening inside the tumor,” said Dr. E. Antonio Chiocca, MD, PhD, senior author and Chair of Neurosurgery at Brigham and Women’s Hospital. “Instead of guessing whether a therapy is working based on scans alone, we now have a molecular map that shows how and where the immune system is engaging with the tumor.”

While MRI scans appeared to show tumor growth, deeper molecular analyses told a different story. “This study challenges how we approach radiographic progression in glioblastoma” said Dr. Chiocca.

Using single-cell RNA sequencing, proteomics, immunopeptidomics, AI-enabled digital pathology and immune cell profiling, researchers observed a significant decrease in tumor cell content near virus injection sites. In their place, immune cells (including activated CD8+ and CD4+ T cells) proliferated and mounted targeted responses against both viral antigens and glioblastoma-specific markers. “In this study we show that the immune system can be trained to recognize and attack tumor cells through repeated viral therapy, even when imaging suggests failure.”

The study is an early read-out of an ongoing clinical trial, part of a larger collaborative effort supported by Break Through Cancer, uniting researchers from leading institutions including Dana-Farber Cancer Institute, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Memorial Sloan Kettering Cancer Center, MIT’s Koch Institute for Integrative Cancer Research, and The University of Texas MD Anderson Cancer Center to intercept and cure the deadliest cancers.

The findings signal a future model for glioblastoma research, one where treatment is guided not just by what can be seen on a scan, but by what is happening at the cellular and molecular level inside the tumor itself. This approach could help accelerate the development of more effective therapies for a disease for which progress has been stagnant for decades.

“This study reflects the kind of transformative collaboration Break Through Cancer was created to enable. It opens the door to smarter, more adaptive treatment strategies that can improve how new treatments are assessed and developed for patients with this devastating disease. “Tyler Jacks, PhD, President of Break Through Cancer.

# # #

About Break Through Cancer

Founded in 2021, Break Through Cancer empowers outstanding researchers and physicians to both intercept and find cures for several of the deadliest cancers by stimulating radical collaboration among outstanding cancer research institutions, including its founding partners: Dana-Farber Cancer Institute, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Memorial Sloan Kettering Cancer Center, MIT’s Koch Institute for Integrative Cancer Research, and The University of Texas MD Anderson Cancer Center.

The Foundation is supported by a Board of Directors from the five partner institutions and a Scientific Advisory Board of U.S. cancer experts. The Foundation was launched with an extraordinary challenge pledge of $250 million from Mr. and Mrs. William H. Goodwin, Jr. and their family, and the estate of William Hunter Goodwin III.

For further information, please visit the Foundation’s website at www.breakthroughcancer.org.

END



ELSE PRESS RELEASES FROM THIS DATE:

Repeated brain tumor sampling uncovers treatment response in patients with glioblastoma

2025-10-08
A multi-institutional study from the Accelerating GBM Therapies Through Serial Biopsies TeamLab, led by investigators from the Mass General Brigham Cancer Institute, found that serially testing tumor samples can help detect when a cancer treatment is activating the immune system in recurrent glioblastoma (GBM), even when traditional imaging measures cannot. Their results are published in Science Translational Medicine.   GBM is the most aggressive type of brain cancer, known for growing and spreading quickly. It is challenging to treat and almost always comes back. But it can be hard to understand ...

Novel immunotherapy combination destroys colorectal liver metastases

2025-10-08
Advanced colon cancer is the leading cause of cancer-related death in young American men and the second highest worldwide. In the majority of these patients, as the cancer advances it metastasizes to the liver. Despite progress in surgical therapies aimed at eradicating the cancer, many of these patients will have tumor recurrence in the liver. Now, researchers from UC San Francisco (UCSF), have discovered that a novel combination of immunotherapies can reprogram the immune environment of colon cancer tumors that spread to the liver. In preclinical models, this therapy often eliminated tumors entirely, offering a potential new path for ...

Farmed totoaba could curb poaching

2025-10-08
(Santa Barbara, Calif.) — The trade of totoaba has all the intrigue of a crime thriller. Dollars and drugs change hands as a criminal cartel vies against the government. Communities and endangered species are caught in the crosshairs of a lucrative illicit trade. It may then come as a surprise that the totoaba is a fish. The totoaba is a large, yet unassuming, species of fish native to the Gulf of California. But its mundane appearance belies incredible value on the black market. “Totoaba swimbladder can sell for up to $80,000 USD per kilogram ...

Avalanches: user-carried safety device increases survival time fivefold

2025-10-08
When the Norwegian company that manufactures the Safeback SBX device which is already on the market, approached Eurac Research to have it independently tested, it was clear that the international research team led by physician and researcher Giacomo Strapazzon would publish the results of the study in any case, regardless of the outcome. For the researchers, the experiment posed a significant challenge, as many participants were completely buried in snow, raising concerns that over two-thirds might require urgent excavation. The volunteer group – composed entirely of enthusiastic ski mountaineers, roughly half of them women – ranged from ...

It’s all in your head: Select neurons in the brainstem may hold the key to treating chronic pain

2025-10-08
Acute or short-lived pain, despite its bad reputation, is usually a lifesaver. It acts as a transient negative sensory experience that helps us avoid danger. Touch a hot stove, stub a toe, or bonk your head on a low branch, and the nervous system cues up an “Ow!” Over time, the sting fades, the wound heals, but the lesson sticks. Chronic pain is different; the alarm keeps blaring long after the fire is out, and then the pain itself becomes the problem. Nearly 50 million people in the United ...

Time-restricted eating can boost athletes' health and performance

2025-10-08
  According to a study by researchers at the Universitat Oberta de Catalunya (UOC), time-restricted feeding can have a positive impact on athletes in terms of both their health and performance. The effects of time-restricted eating – where food intake is permitted within a restricted window ranging from 3-4 to 10-12 hours – have been widely studied in the general population, where they have been shown to increase life expectancy, but there is little evidence on its positive effects on high-performance athletes. The study – "Effect of time-restricted feeding ...

Burning issue: study finds fire a friend to some bees, a foe to others

2025-10-08
New Curtin University research has found the impact of bushfires and prescribed burns on global bee populations is highly varied, with some species benefiting from fire while others face severe risks.   The study, led by Adjunct Research Fellow Dr Kit Prendergast from Curtin’s School of Molecular and Life Sciences, examined 148 studies from around the world to understand how fire impacts bees.   The review considered the severity, frequency and duration of fires, along with the different characteristics of bees, such as where they ...

Insights from 15 years of collaborative microbiome research with Indigenous peoples in the Peruvian Amazon

2025-10-08
Forming sustainable research partnerships with Indigenous peoples requires trust and mutual benefit, say microbiome researchers in an opinion paper publishing October 8 in the Cell Press journal Trends in Microbiology. The paper presents a framework for building this type of relationship based on insights from the team’s 15-year-long collaboration with the Matsés, a group of people who live in the Amazon rainforest on the border of Peru and Brazil. To build trust, the researchers worked in collaboration with the Matsés through all stages of the research project, from developing research methods to disseminating results.  “Establishing genuine partnerships with ...

Designing polymers for use in next-generation bioelectronics

2025-10-08
Engineered polymers hold promise for use in next generation technologies such as light-harvesting devices and implantable electronics that interact with the nervous system – but creating polymers with the right combination of chemical, physical and electronic properties poses a significant challenge. New research offers insights into how polymers can be engineered to fine-tune their electronic properties in order to meet the demands of such specific applications. “Silicon-based electronics have been around for decades, and we have a thorough understanding of the electronic properties of materials used in those technologies,” says Aram Amassian, co-corresponding author of ...

Losing Nemo: Almost all aquarium fish in the US are caught in the wild

2025-10-08
New research has revealed that about 90 percent of marine aquarium fish sold by online retailers in the United States are sourced directly from wild populations, mostly in the western Pacific and Indian Ocean. With the US accounting for around two-thirds of all global aquarium fish imports, researchers warn that this reliance on wild capture threatens the sustainability of coral reef ecosystems and puts endangered and threatened species at greater risk of extinction. The research, led by postdoctoral research associate Dr Bing Lin from the University of Sydney’s Thriving Oceans Research Hub in the School of Geosciences, analysed data from four major US-based online aquarium ...

LAST 30 PRESS RELEASES:

Modern twist on wildfire management methods found also to have a bonus feature that protects water supplies

AI enables defect-aware prediction of metal 3D-printed part quality

Miniscule fossil discovery reveals fresh clues into the evolution of the earliest-known relative of all primates

World Water Day 2026: Applied Microbiology International to hold Gender Equality and Water webinar

The unprecedented transformation in energy: The Third Energy Revolution toward carbon neutrality

Building on the far side: AI analysis suggests sturdier foundation for future lunar bases

Far-field superresolution imaging via k-space superoscillation

10 Years, 70% shift: Wastewater upgrades quietly transform river microbiomes

Why does chronic back pain make everyday sounds feel harsher? Brain imaging study points to a treatable cause

Video messaging effectiveness depends on quality of streaming experience, research shows

Introducing the “bloom” cycle, or why plants are not stupid

The Lancet Oncology: Breast cancer remains the most common cancer among women worldwide, with annual cases expected to reach over 3.5 million by 2050

Improve education and transitional support for autistic people to prevent death by suicide, say experts

GLP-1 drugs like Ozempic could cut risk of major heart complications after heart attack, study finds

Study finds Earth may have twice as many vertebrate species as previously thought

NYU Langone orthopedic surgeons present latest clinical findings and research at AAOS 2026

New journal highlights how artificial intelligence can help solve global environmental crises

Study identifies three diverging global AI pathways shaping the future of technology and governance

Machine learning advances non targeted detection of environmental pollutants

ACP advises all adults 75 or older get a protein subunit RSV vaccine

New study finds earliest evidence of big land predators hunting plant-eaters

Newer groundwater associated with higher risk of Parkinson’s disease

New study identifies growth hormone receptor as possible target to improve lung cancer treatment

Routine helps children adjust to school, but harsh parenting may undo benefits

IEEE honors Pitt’s Fang Peng with medal in power engineering

SwRI and the NPSS Consortium release new version of NPSS® software with improved functionality

Study identifies molecular cause of taste loss after COVID

Accounting for soil saturation enhances atmospheric river flood warnings

The research that got sick veterans treatment

Study finds that on-demand wage access boosts savings and financial engagement for low-wage workers

[Press-News.org] Real-time biopsies uncover hidden response to glioblastoma therapy
Early clinical trial results show that serial brain biopsies reveal immune activity in brain cancer not captured by standard scans